Rhode Island House Bill H7535

Rhode Island 2026 Regular Session

• Introduced: 2/6/26
• Refer: 2/6/26

Caption

Requires certain health care facilities to allow a terminally ill patient’s use of medicinal cannabis within the health care facility, subject to certain restrictions.

Impact

By permitting the use of medicinal cannabis in healthcare settings, H7535 could significantly alter how terminally ill patients engage with their treatment plans. The bill stipulates that healthcare facilities must follow guidelines that protect both patients and the integrity of the care provided. This includes requirements such as maintaining records of cannabis use, prohibiting smoking or vaping methods, and establishing secure storage protocols for cannabis products. The legislation seeks to align more closely with the provisions of the Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act, ensuring that patients have the compassionate access they need while balancing safety and regulatory compliance.

Summary

House Bill H7535, titled the "Compassionate Access to Medical Cannabis Act", proposes to amend existing regulations surrounding the use of medicinal cannabis in healthcare facilities. Specifically, the bill mandates that certain healthcare providers allow terminally ill patients to utilize medicinal cannabis while receiving care in these facilities, establishing a framework for how this should be managed safely and responsibly. The intent of the bill is to ensure terminally ill patients can access their recommended treatments in a supportive healthcare environment without facing undue restrictions.

Contention

Debates surrounding H7535 may revolve around the complexities of integrating cannabis use into traditional medical settings amidst federal regulations that classify cannabis as a Schedule I drug. Concerns about liability, compliance with federal laws, and the interpretation of patients' rights in terms of medical cannabis access are likely points of discussion. The bill includes provisions allowing healthcare facilities to suspend compliance if federal authorities enforce regulations that conflict with this bill. This dual regulatory landscape could raise questions about the real-world application of this law and its impact on patient care, particularly in cases where healthcare professionals may feel pressured by conflicting local and federal regulations.